Abstract
Homeobox A1 (HOXA1) serves an oncogenic role in multiple cancer types. However, the role of HOXA1 in non-small cell lung cancer (NSCLC) remains unclear. In the present study, use of reverse transcription-quantitative polymerase chain reaction and the databases of The Cancer Genome Atlas (TCGA), Oncomine, Gene Expression Profiling Interactive Analysis and the Multi Experiment Matrix were combined to assess the expression of HOXA1 and its co-expressed genes in NSCLC. Bioinformatic analyses, such as Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and network and protein-protein interaction analyses, were used to investigate the underlying molecular mechanism effected by the co-expressed genes. Additionally, the potential miRNAs targeting HOXA1 were investigated.
Cite
CITATION STYLE
Zhang, Y., Li, X. J., He, R. Q., Wang, X., Zhang, T. T., Qin, Y., … Chen, G. (2018). Upregulation of HOXA1 promotes tumorigenesis and development of non-small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis. International Journal of Oncology, 53(1), 73–86. https://doi.org/10.3892/ijo.2018.4372
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.